Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Vitamin C in Septic ARDS (LOVIT-ARDS)
NCT04404387Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid in sepsis, acute respiratory distress syndrome (ARDS), sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2022; status: recruiting.
02
Drugs
ascorbic acid
03
Conditions
sepsisacute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04404387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04404387.